Home / Product / Company Analysis
NeuraCap

Company Analysis: one company, one evidence chain.

Evaluate a public or private company through executive context, competitor metrics, KPI benchmarking, market data, valuation and relevant transaction context.

The company workspace

Start with the company. Build the evidence around it.

Company Analysis is the core evaluation workspace. It brings the company summary, comparable companies, KPI benchmarks, market data and valuation surfaces into the same analytical thread.

01
Executive SummaryRevenue, EPS and company context
02
Company + peersComparable company metrics
03
KPI BenchmarkingHorizontal peer comparison
04
ValuationMarket data + Football Field
NeuraCap company valuation metrics view with comparable-company data.
Company valuation metrics view showing company and comparable-company financial and valuation context.
1 · Company + competitor table

See the company and its competitors in the same frame.

The peer table is the reference layer for everything that follows. It can combine current market information with reported and forward financial metrics so the analyst can understand relative positioning before interpreting the charts.

Market dataPrice, market value and valuation fields
Reported financialsHistorical revenue, EBITDA and related metrics
Forward financialsConsensus estimates shown separately from reported figures
Peer setComparable companies selected for the evaluation
MARKET

Market data

Public-company market context and valuation fields provide the starting point for relative analysis.

CURRENT

Reported financials

Historical reported metrics are structured for comparison across the selected company set.

FORWARD

Forward estimates

Forward consensus estimates are shown separately from reported figures and remain subject to revision.

2 · KPI Benchmarking

Compare the operating story with a horizontal peer chart.

The KPI Benchmarking surface compares the selected company with competitors across relevant operating and financial KPIs. The current product screen already provides the clearest approved evidence, so the page uses that screen directly rather than adding an artificial placeholder.

NeuraCap KPI benchmarking view comparing company metrics with selected peers.
KPI benchmarking view comparing company revenue growth and EBITDA margin with selected peers using horizontal bars and peer-average markers.
EXAMPLE METRICS

Growth and margin

Revenue growth, EBITDA margin and other relevant KPIs can show whether the target sits above, below or around its peer set.

INTERPRETATION

Percentile positioning

Benchmarking becomes useful when the analyst can see relative positioning rather than a list of disconnected numbers.

3 · Market Data

Move from company metrics to market behavior.

The market-data surface provides historical price context and related market fields for public companies. A dedicated candlestick/OHLCV capture is not in the approved asset set yet, so this section documents the workflow without inventing a chart.

Price historyHistorical market movement for the selected public company
Trading contextMarket fields used alongside the company and peer view
ChartDedicated candlestick view can be added when the approved product capture is available
4 · Football Field

Turn multiple evidence layers into a valuation range.

The Football Field brings valuation ranges into one investment-banking presentation surface. It can show public-comparable and transaction-based ranges alongside other supported methodologies.

  • Public company comparables
  • Precedent transactions
  • Methodology ranges
  • Implied aggregate valuation context
NeuraCap Football Field valuation chart showing multiple valuation methodologies.
Football Field valuation view showing valuation ranges from trading, comparable-company and precedent-transaction context.
5 · Transaction context

Company Analysis can carry relevant M&A evidence into the valuation story.

The dedicated M&A surface is where transaction research happens in depth. Company Analysis uses the relevant transaction context as another evidence layer rather than treating M&A as a completely separate product.

NeuraCap precedent transactions table with transaction and valuation data.
Precedent transaction table showing selected M&A deal fields and valuation multiples.
How the pieces connect

The chart is only useful when the evidence behind it is coherent.

Company Analysis is designed to move from raw company context to relative benchmarking and then to valuation. The analyst remains responsible for selecting the right peers and interpreting the result.

Source dataNormalized dataCalculated metricsConnected analysisAI-assisted interpretation
See the workflow

Evaluate more companies with less manual research.

Request a demo to see NeuraCap applied to the company-evaluation workflow.

Request a Demo